We are live on ! Find out more
DSCI

Derma Sciences, Inc. Common Stock (DE)
DSCI

Delisted

DSCI was delisted on the 23rd of February, 2017.

Back to rankings

71 hedge funds and large institutions have $274M invested in Derma Sciences, Inc. Common Stock (DE) in 2014 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 36 increasing their positions, 6 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 6

200% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 8

97% more capital invested

Capital invested by funds: $140M → $274M (+$135M)

29% more funds holding

Funds holding: 55 → 71 (+16)

Holders
71
Holders Change
+16
Holders Change %
+29.09%
% of All Funds
2.05%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
24
Increased
36
Reduced
6
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$13.3M
2
BBA
Baker Bros. Advisors
New York
+$12.6M
3
GPP
Great Point Partners
Connecticut
+$12M
4
CCM
Consonance Capital Management
New York
+$11.5M
5
BC
Broadfin Capital
New York
+$10.3M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$8.48M
2
First Manhattan
First Manhattan
New York
-$5.41M
3
CCM
Camber Capital Management
Massachusetts
-$5.38M
4
RCM
Raging Capital Management
New Jersey
-$1.19M
5
TS
Third Security
Virginia
-$852K
Name Holding Trade Value Shares
Change 		Change in
Stake
State Street
26
State Street
Massachusetts
$2.99M +$972K +75,232 +47%
BIT
27
BlackRock Institutional Trust
California
$2.71M +$1.03M +79,782 +60%
SM
28
Senvest Management
New York
$2.29M +$2.33M +180,531 New
Bank of New York Mellon
29
Bank of New York Mellon
New York
$1.59M +$115K +8,913 +8%
Geode Capital Management
30
Geode Capital Management
Massachusetts
$1.54M +$857K +66,288 +120%
EIM
31
Essex Investment Management
Massachusetts
$1.48M +$296K +22,921 +25%
Renaissance Technologies
32
Renaissance Technologies
New York
$1.21M +$1.23M +95,281 New
CCM
33
Cadence Capital Management
Massachusetts
$1M +$174K +13,425 +21%
BIM
34
BlackRock Investment Management
Delaware
$867K +$283K +21,901 +47%
CB
35
Commerce Bank
Missouri
$836K -$86.6K -6,700 -9%
TCIM
36
TIAA CREF Investment Management
New York
$787K -$6.72K -520 -0.8%
RA
37
Royce & Associates
New York
$697K – – –
California Public Employees Retirement System
38
California Public Employees Retirement System
California
$614K +$64.6K +5,000 +10%
Deutsche Bank
39
Deutsche Bank
Germany
$526K +$501K +38,721 +1,341%
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$468K +$156K +12,100 +49%
PG
41
PEAK6 Group
Illinois
$460K +$469K +36,278 New
RAM
42
Roanoke Asset Management
New Jersey
$415K – – –
HCMT
43
Highland Capital Management (Texas)
Texas
$380K +$388K +30,000 New
UOC
44
UBS O'Connor
Illinois
$380K +$388K +30,000 New
Charles Schwab
45
Charles Schwab
California
$362K +$103K +8,000 +39%
TA
46
Teachers Advisors
New York
$320K +$95.4K +7,380 +41%
OAM
47
Oxford Asset Management
United Kingdom
$308K +$314K +24,270 New
TC
48
TFS Capital
Pennsylvania
$303K +$308K +23,865 New
Allianz Asset Management
49
Allianz Asset Management
Germany
$287K – – –
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$265K +$41.8K +3,230 +18%
1
2
3 4

DSCI Hedge Fund Activity: Q1 2014 in Review

71 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Derma Sciences, Inc. Common Stock (DE) (DSCI) for Q1 2014, worth a combined $274M — up 97% from $140M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new DSCI positions and 8 closed out — a net gain of 16 holders — while 36 added to existing stakes and 6 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $13.3M. The largest seller was RA Capital Management, cutting an estimated $8.48M.

  • 71 institutional investors held Derma Sciences, Inc. Common Stock (DE) (DSCI) as of Q1 2014, up from 55 in Q4 2013.
  • Funds reported $274M of Derma Sciences, Inc. Common Stock (DE) stock for Q1 2014, up 97% quarter-over-quarter.
  • 24 funds opened new Derma Sciences, Inc. Common Stock (DE) positions in Q1 2014 and 8 closed out, a net change of +16 holders.
  • The largest Derma Sciences, Inc. Common Stock (DE) buyer in Q1 2014 was JP Morgan Chase, an estimated $13.3M added.
  • The largest Derma Sciences, Inc. Common Stock (DE) seller in Q1 2014 was RA Capital Management, an estimated $8.48M sold.

Based on aggregated 13F filings for Q1 2014.